Summary of the 2006 College of American Pathologists Gynecologic Cytology Proficiency Testing Program.
نویسندگان
چکیده
CONTEXT Creating a tool that assesses professional proficiency in gynecologic cytology is challenging. A valid proficiency test (PT) must reflect practice conditions, evaluate locator and interpretive skills, and discriminate between those practitioners who are competent and those who need more education. The College of American Pathologists Gynecologic Cytology Proficiency Testing Program (PAPPT) was approved to enroll participants in a nationwide PT program in 2006. OBJECTIVE Report results from the 2006 PAPPT program. DESIGN Summarize PT results by pass/fail rate, participant type, and slide-set modules. RESULTS Nine thousand sixty-nine participants showed initial PT failure rates of 5%, 16%, and 6% for cytotechnologists, primary screening pathologists, and secondary screening pathologist, respectively. The overall initial test failure rate was 6%. After 3 retests, 9029 (99.6%) of the participants were able to achieve compliance with the PT requirement. No participant "tested out"; however, 40 individuals "dropped out" of the testing sequence (8 cytotechnologists, 9 primary screening pathologists, 23 secondary screening pathologists). Initial failure rates by slide-set modules were 6% conventional, 6% ThinPrep, 6% SurePath, and 5% mixture of all 3 slide types. CONCLUSIONS A total of 99.6% of individuals enrolled in the 2006 PAPPT program achieved satisfactory results. The data confirm that cytotechnologists have higher initial pass rates than pathologists and pathologists who are secondary screeners perform better than those who are primary screeners. There was no difference identified in overall pass rates between the slide-set modules. Further analysis of data should help define the results and ongoing challenges of providing a nationwide federally mandated proficiency testing program in gynecologic cytology.
منابع مشابه
Room for improvement: initial experience with anal cytology: observations from the College of American Pathologists interlaboratory comparison program in nongynecologic cytology.
CONTEXT Anal cytology is being used more frequently for anal cancer screening, yet many cytologists are unfamiliar with it. OBJECTIVE To describe the performance of anal cytology in the College of American Pathologists' Interlaboratory Comparison Program in Non-Gynecologic Cytology (CAP NGC) educational slide program during a 6-year time span, from 2006 to 2011, using participant responses (p...
متن کاملProficiency testing as a regulatory device: a CAP perspective.
The history and development of the proficiency testing programs of the College of American Pathologists are reviewed. Important considerations of external surveys include target value assignment and determination of acceptable ranges. "Blind" proficiency testing and on-site evaluation provide alternative methods of laboratory evaluation but are limited by practical logistics.
متن کاملScientific issues related to the cytology proficiency testing regulations
The member organizations of the CETC feel strongly that there are significant flaws associated with the proposed proficiency test and its implementation. The most immediate modifications include lengthening the required testing interval, utilizing stringently validated and continuously monitored slides, changing the grading scheme and changing the focus of the test from individuals to laborator...
متن کاملMethyl orange as a screening reagent for organic bases.
and develop comparable regulatory programs for their state or (b) require intrastate clinical laboratories providing toxicological services to participate in the toxicology proficiency program now being separately developed by the National Center for Disease Control or the College of American Pathologists. The failure to provide adequate safeguards by mandatory drug-abuse proficiency testing op...
متن کاملLaboratory Compliance With the American Society of Clinical Oncology/College of American Pathologists Guidelines for Human Epidermal Growth Factor Receptor 2 Testing
N Context.—To ensure quality human epidermal growth receptor 2 (HER2) testing in breast cancer, the American Society of Clinical Oncology/College of American Pathologists guidelines were introduced with expected compliance by 2008. Objective.—To assess the effect these guidelines have had on pathology laboratories and their ability to address key components. Design.—In late 2008, a survey was d...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Archives of pathology & laboratory medicine
دوره 132 5 شماره
صفحات -
تاریخ انتشار 2008